Gene: ENO2 ×
Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 2026
Gene Symbol: ENO2
ENO2 		0.100 Biomarker disease BEFREE Usefulness of neuron specific enolase in prognostication after cardiac arrest: Impact of age and time to ROSC. 31022497 2019
Entrez Id: 2026
Gene Symbol: ENO2
ENO2 		0.100 Biomarker disease BEFREE We determined the NSE concentrations from serum samples at 48 h after cardiac arrest and assessed neurological outcome with the Cerebral Performance Category (CPC) scale at 6 months. 31088512 2019
Entrez Id: 2026
Gene Symbol: ENO2
ENO2 		0.100 AlteredExpression disease BEFREE We examined the prognostic performance between CSF NSE and serum NSE levels in out-of-cardiac arrest (OHCA) survivors who had undergone target temperature management (TTM). 31585184 2019
Entrez Id: 2026
Gene Symbol: ENO2
ENO2 		0.100 Biomarker disease BEFREE Serial NSE measurement identifies non-survivors following out of hospital cardiac arrest. 29679695 2018
Entrez Id: 2026
Gene Symbol: ENO2
ENO2 		0.100 Biomarker disease BEFREE Even if S-100B protein dosage performs slightly better than NSE, early dosages of these biomarkers are poorly predictive of a cerebrovascular etiology of CA. 29981819 2018
Entrez Id: 2026
Gene Symbol: ENO2
ENO2 		0.100 Biomarker disease BEFREE Serum neuron-specific enolase (NSE) levels have been shown to correlate with neurologic outcome in comatose survivors of cardiac arrest but use of absolute NSE thresholds is limited. 30145080 2018
Entrez Id: 2026
Gene Symbol: ENO2
ENO2 		0.100 Biomarker disease BEFREE The primary outcome was the serum concentration of neuron-specific enolase (NSE) at 48 h after cardiac arrest. 30443729 2018
Entrez Id: 2026
Gene Symbol: ENO2
ENO2 		0.100 Biomarker disease BEFREE SSEP, EEG and NSE may indicate absence of severe HIE early after CA. 29990580 2018
Entrez Id: 2026
Gene Symbol: ENO2
ENO2 		0.100 Biomarker disease BEFREE The primary endpoint was the serum concentration of neuron-specific enolase (NSE) 48 h after cardiac arrest. 30430209 2018
Entrez Id: 2026
Gene Symbol: ENO2
ENO2 		0.100 Biomarker disease BEFREE The daily changes in NSE from admission to Day 2 after the cardiac arrest (CA) were also related to the outcome (p=0.003 and p=0.02). 29175384 2018
Entrez Id: 2026
Gene Symbol: ENO2
ENO2 		0.100 Biomarker disease BEFREE The primary outcome is neuron-specific enolase (NSE) serum concentration at 48 h after cardiac arrest. 29084585 2017
Entrez Id: 2026
Gene Symbol: ENO2
ENO2 		0.100 Biomarker disease BEFREE The highest associations of NSE with outcomes were observed on day 4 and day 3 after cardiac arrest. 28687073 2017
Entrez Id: 2026
Gene Symbol: ENO2
ENO2 		0.100 AlteredExpression disease BEFREE Blood samples were obtained at 48 hrs after cardiac arrest for the determination of microRNA levels and neuron-specific enolase. 22890253 2012
Entrez Id: 2026
Gene Symbol: ENO2
ENO2 		0.100 Biomarker disease LHGDN Serum neuron-specific enolase as early predictor of outcome after in-hospital cardiac arrest: a cohort study. 16978415 2006
Entrez Id: 2026
Gene Symbol: ENO2
ENO2 		0.100 AlteredExpression disease LHGDN Serum neuron-specific enolase and S-100B protein in cardiac arrest patients treated with hypothermia. 14631087 2003